TurboVets is fully live. For support, please submit tickets in app.
Sign In to TurboVets
Your Data is Protected. Never Sold. Never Used for Profit.
Read our FAQ
7718
§ 4.117 Schedule of ratings—hemic and lymphatic systems.

Myelofibrosis

Bone marrow disorder with fibrous tissue replacement, leading to anemia and enlarged spleen

What the rating means

VA rates essential thrombocythemia and primary myelofibrosis under diagnostic code 7718. Four ratings are possible: 100%, 70%, 30%, and 0%.

A 100% rating applies when your condition requires continuous myelosuppressive therapy, or for six months following a hospital admission for a peripheral blood or bone marrow stem cell transplant, chemotherapy, or interferon treatment. The 100% rating starts on the date of hospital admission for a transplant, or during the period of chemotherapy or interferon treatment. Six months after hospital discharge or after chemotherapy ends, VA will schedule a mandatory examination to determine the appropriate rating going forward.

A 70% rating applies when your condition requires continuous or intermittent myelosuppressive therapy, chemotherapy, or interferon treatment to keep your platelet count below 500 × 10/L.

A 30% rating applies when treatment is needed to maintain a platelet count of 200,000–400,000 or a white blood cell count of 4,000–10,000.

A 0% rating applies when you are asymptomatic. If the condition transforms into leukemia, VA evaluates it under diagnostic code 7703 instead.

Evidence that helps

The evidence that matters most for this condition ties directly to what treatment you are receiving and what your blood counts show.

For the 100% rating, medical records showing a hospital admission for a peripheral blood or bone marrow stem cell transplant, chemotherapy, or interferon treatment are central. Discharge summaries, admission dates, and treatment records help establish both that the treatment occurred and when it ended.

For the 70% rating, records showing that continuous or intermittent myelosuppressive therapy, chemotherapy, or interferon treatment is prescribed, along with laboratory results showing platelet counts below 500 × 10/L, support this level.

For the 30% rating, prescription records and lab results showing platelet counts in the 200,000–400,000 range or white blood cell counts of 4,000–10,000 while on therapy are relevant.

For any rating level, treatment records from your hematologist or oncologist, pharmacy records showing current prescriptions, and dated laboratory reports are the most direct forms of evidence. Statements from you or those who know you describing how symptoms and treatment affect your daily life and ability to work can also support your overall picture.

Secondary conditions

Conditions that are often caused or made worse by this one. If you have any of these, they may be claimable as secondary service connection.